Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Short answer. In United States Pharmacopeia (USP) terms, controlled room temperature (CRT) is 20 to 25 °C, with excursions permitted between 15 and 30 °C. That is the wording FDA-approved drug labeling points to, and it is the reading to apply when a product label says “store at controlled room temperature.” A USP proposal would move the lower bound to 15 °C, so confirm the range printed on the label in front of you.
General information for supply, laboratory and clinic staff, not medical advice. The label or instructions for use from the manufacturer always governs the product in your hands.
Definition and scope
Controlled room temperature is a defined storage term, not a description of how warm a room feels. USP currently defines it as 20 to 25 °C, with excursions permitted from 15 to 30 °C,, as stated in the public preview of the proposed revision of USP General Chapter <659> (checked 2026-11-01). The excursion band is part of the definition, so a stated range and its permitted excursions should be read together.
The term comes from pharmacopeial standards written for drug products. Many medical supplies and laboratory consumables carry their own storage statements set by the manufacturer, and those statements, not a drug chapter, decide what is acceptable. Use this page to read the wording correctly, not to infer a rule for a product whose label says something else. For where storage zones and records fit into a whole facility, see the medical warehouse guide.
How the term is used in practice: reading a label
FDA-approved drug labeling shows the pattern. The 2025 prescribing information for NUBEQA (darolutamide), for example, reads in its Storage and Handling section: “Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]” (FDA label, checked 2026-11-01). Treat this as an example of how the term is written, not as a rule for any other product.
A practical receiving checklist for any storage statement:
- Exact wording. Is it “controlled room temperature,” a stated range such as 20 to 25 °C, or a looser phrase such as “room temperature”? These are not interchangeable.
- The stated range and units. Record both Celsius and Fahrenheit if the label gives them.
- The excursion allowance. Does the label state permitted excursions, and between what limits?
- The cross-reference. A pointer to USP means the USP definition applies; a manufacturer-specific range means that range applies.
- The record. Note the storage statement and the temperature data for the shipment or storage area in your receiving or inventory log, so a later question about a deviation can be answered from the record.
Asking the supplier for the manufacturer’s storage statement and any temperature data for the shipment is a reasonable documentation request. It is a generic good-practice step on this page, not a requirement from a named standard. For monitoring equipment, see the temperature monitoring system guide; for how storage areas are verified, see the temperature mapping protocol.
Current and proposed USP range
| Item | Current USP definition | Proposed revision |
|---|---|---|
| Controlled room temperature | 20 to 25 °C | 15 to 25 °C, aligning with other pharmacopeias that define room temperature as 15 to 25 °C |
| Excursions | Permitted between 15 °C and 30 °C | Mean kinetic temperature (MKT) principles retained for assessing excursions |
Source: USP-NF General Chapter <659> Packaging and Storage Requirements, public preview of the proposed revision (checked 2026-11-01); trade-press coverage of Pharmacopeial Forum 52(4) from gmp-compliance.org reports a comment deadline of 30 September 2026 (checked 2026-11-01). This is a proposal. Until the revision is published as official, the current definition above stands, so check the current USP-NF before citing either range. For mean kinetic temperature itself, see the MKT dictionary entry.
Where it matters for labs, clinics and supply decisions
The USP preview cites chapter <1079.2>, which states that the maximum allowable excursion duration is 24 hours, and that storage time under controlled cold or cool conditions cannot be used to offset excursions outside CRT ranges. Two consequences follow for records:
- Excursions are time-bound. An excursion log should show duration as well as peak temperature.
- Cold does not cancel heat. A cold period does not “bank” credit against a warm excursion, so each excursion is assessed on its own.
Shipping and cold-chain handling, where temperature bands and excursions are managed across a distribution route, are covered in the pharma cold chain logistics guide.
Common misunderstandings
Is controlled room temperature the same as “room temperature”?
No. CRT is a USP-defined term with a stated range and excursion band. “Room temperature” without a definition has no fixed range, and the proposed USP change cites other pharmacopeias that define room temperature as 15 to 25 °C.
Can a cold period make up for a warm one?
No. Per USP <1079.2>, as cited in the USP preview, storage time under controlled cold or cool conditions cannot be used to offset excursions outside CRT ranges.
Does the 15 to 25 °C proposal already apply?
No. The change is a proposal; the current USP definition remains 20 to 25 °C until a revised chapter is made official.
FAQ
What is controlled room temperature for medical supplies?
For products whose labeling cites USP, it is 20 to 25 °C with excursions permitted between 15 and 30 °C. For other supplies, the manufacturer’s stated storage condition applies.
What is controlled room temperature storage for medical supplies in a clinic or lab?
It means keeping stock within the label’s stated range, with a temperature record that can show any excursion’s size and duration. The label states the range; the USP definition applies where the label cites it.
How long can an excursion last?
USP <1079.2>, as cited in the USP preview, gives a maximum allowable excursion duration of 24 hours. The product’s own label governs for that product.
Sources
- USP-NF General Chapter <659> Packaging and Storage Requirements, public preview of proposed revision (DOI 10.31003/USPNF_M2773_60101_01): https://doi.usp.org/USPNF/USPNF_M2773_60101_01.html. Date checked: 2026-11-01.
- FDA prescribing information, NUBEQA (darolutamide), 2025, Storage and Handling: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212099s008lbl.pdf. Date checked: 2026-11-01.
- gmp-compliance.org, “USP proposes to revise the definition of controlled room temperature in chapter 659” (trade press on Pharmacopeial Forum 52(4)): https://www.gmp-compliance.org/gmp-news/usp-proposes-to-revise-the-definition-of-controlled-room-temperature-in-chapter-659. Date checked: 2026-11-01.







